The following question might arise for the reader: if pro-tumoral estrogens are synthesized and act on the ovarian tumor, why then do inhibitors of estrogen biosynthesis or estrogen receptor antagonists have but little effect on disease progression? Here, ESR1 is linked to ovarian neoplasm.